AwesomeCapital: GSK: SUBMITTED BLA TO FDA FOR PRIORIX FOR USE IN MMR ACTIVE IMMUNIZATION

Monday, August 2, 2021

GSK: SUBMITTED BLA TO FDA FOR PRIORIX FOR USE IN MMR ACTIVE IMMUNIZATION

SEEKING APPROVAL FOR USE IN ACTIVE IMMUNIZATION AGAINST INFECTION BY MEASLES, MUMPS AND RUBELLA (MMR)

https://www.marketscreener.com/news/latest/GSK-SUBMITTED-A-BLA-TO-U-S-FDA-FOR-PRIORIX-SEEKING-APPROVAL-FOR-USE-IN-ACTIVE-IMMUNIZATION-AGAIN--36043226/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)